Free Trial
→ Here’s Why Trump Won’t End The Iran War (From Banyan Hill Publishing) (Ad)tc pixel Free LXEO Stock Alerts

Lexeo Therapeutics (LXEO) Earnings Date, Estimates & Call Transcripts

Lexeo Therapeutics logo
$2.63 -0.11 (-4.01%)
Closing price 04:00 PM Eastern
Extended Trading
$2.63 0.00 (0.00%)
As of 04:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Lexeo Therapeutics Earnings Summary

Lexeo Therapeutics issued Q2 2026 earnings on August 12, 2026, reporting an EPS of -$0.30, which missed analysts' consensus estimates of -$0.29 by $0.01. With a trailing EPS of -$1.15, Lexeo Therapeutics' earnings are expected to decrease next year, from ($1.18) to ($1.44) per share.

Upcoming Q3
Earnings Date
Dec. 14Before Market OpensEstimated
Consensus EPS
(Aug. 12)
-$0.29
Actual EPS
(Aug. 12)
-$0.30 Missed By -$0.01

Q2 2026 Earnings Resources

LXEO Upcoming Earnings

Lexeo Therapeutics' next earnings date is estimated for Monday, December 14, 2026, based on past reporting schedules.

Powered by Quartr
Get Lexeo Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lexeo Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

LXEO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Lexeo Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.33-$0.33-$0.33
Q2 20261-$0.32-$0.32-$0.32
Q3 20261-$0.34-$0.34-$0.34
Q4 20261-$0.36-$0.36-$0.36

Lexeo Therapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
12/14/2026
(Estimated)		--------
8/12/2026Q2 2026-$0.2852-$0.30 -$0.0148-$0.30--
5/11/2026Q1 2026-$0.29-$0.25+$0.04-$0.25--
3/30/2026Q4 2025-$0.32-$0.27+$0.05-$0.27--
11/5/2025Q3 2025-$0.48-$0.33+$0.15-$0.33--
8/14/2025Q2 2025-$0.64-$0.60+$0.04-$0.60--
5/12/2025Q1 2025-$0.80-$0.99 -$0.19-$0.99--
3/24/2025Q4 2024-$0.87-$0.78+$0.09-$0.78--

Lexeo Therapeutics Earnings - Frequently Asked Questions

Lexeo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 14th, 2026 based off last year's report dates. Learn more on LXEO's earnings history.

In the previous quarter, Lexeo Therapeutics (NASDAQ:LXEO) missed the analysts' consensus estimate of ($0.29) by $0.01 with a reported earnings per share (EPS) of ($0.30). Learn more on analysts' earnings estimate vs. LXEO's actual earnings.

Lexeo Therapeutics (NASDAQ:LXEO) has a recorded net income of -$99.96 million. LXEO has generated -$1.15 earnings per share over the last four quarters.

Lexeo Therapeutics' earnings are expected to decrease from ($1.18) per share to ($1.44) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:LXEO is sourced from Fiscal.ai, with the most recent quarter reported on 8/12/2026. New results are added as companies report their earnings.
From Our Partners
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...
Paradigm Press | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
A new income category is drawing serious money - here's why
Forbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...
Investors Alley | Sponsoredtc pixel
Why Some AI Stocks Already Surged Over 300 Percent
Jason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...
Brownstone Research | Sponsoredtc pixel
The Iran War Isn’t Chaos. It’s Strategy.
Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...
Behind the Markets | Sponsoredtc pixel
Urgent: Invest In ‘Elon’s iPhone’ Before July 22nd
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...
Porter & Company | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel